COVID-19 Antibody Testing
Monitor your infection risk. Understand your immune status.
Monitoring waning immunity and the associated risk of infection post-vaccination or post-infection by measuring the body's neutralizing antibody response can help inform decisions on the appropriate timing for vaccine boosters and steps to limit exposure to COVID-19.
The KSL COVID-19 Immune Index™ — IgG, IgM, IgA Antibody Testing by CLIA Correlated with Virus Neutralization assay helps you understand your immunity by providing accurate, quantitative results to inform decisions regarding vaccination and risk of infection — with laboratory results provided in just two days.
Patients may schedule this quick and easy finger-prick blood test by clicking or tapping on the scheduler on this page.
COVID-19 Immune Index — Correlation of antibody titers with virus neutralization
Authorized Under EUA: This test is not FDA cleared or approved. It is authorized for emergency use under an Emergency Use Authorization (EUA). Testing of specimens is limited to laboratories that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, and meets the requirements to perform high complexity tests. The emergency use of this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19.